On-demand video: Powering the next wave of cardiometabolic care

Following the release of our latest article in ONdrug Delivery magazine, SHL’s Senior Manager of Portfolio Strategy and Customer Solutions, Lars Berger, discussed the pivotal role SHL Medical plays in supporting cardiometabolic care in an exclusive video.  

As the global obesity epidemic the prevalence of cardiometabolic diseases continue to rise, the need for innovative healthcare solutions becomes increasingly urgent. Autoinjectors have emerged as a crucial advancement in supporting the delivery of treatments for cardiometabolic diseases, offering patients convenient and reliable means to manage their conditions at home.

Given the growing pipeline of molecules for cardiometabolic diseases, pharma and biotech companies entering this space need to seek partners with proven device technologies and globally dispersed infrastructure capable of scaling manufacturing. Berger explained in this webcast how SHL’s Molly® autoinjectors are ideally positioned to meet this challenge. Built upon a proven modular platform, Molly reduces risks during the development process while enabling flexibility in device design and production. 

Key highlights:

• Patient-centric autoinjector technologies: Find out how SHL’s Molly autoinjectors support cardiometabolic care at the present time.
• Extensive experience: More insights on SHL Medical’s proven track record in launching combination products for cardiometabolic diseases.
• Scalable manufacturing: Discover how SHL’s vertically integrated manufacturing capabilities keep us ahead in the rapidly evolving field of cardiometabolic care.
• Commitment to patients: Learn more about SHL’s dedication to providing the best user experience for cardiometabolic patients through its extensive research and development efforts
  
  

By collaborating closely with leading pharma and biotech companies, SHL Medical continues to pioneer solutions that redefine standards in cardiometabolic care. Head to the webpage to learn more about this market-proven modular platform technology.